R-Biopharm AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:R-Biopharm AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10468
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
R-Biopharm AG (R-Biopharm), a subsidiary of Rohm Gmbh & Co KG, is a developer of test solutions for clinical diagnostics and food and feed analysis. The company offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for clinical diagnostics. It also provides food analysis test kits for the analysis of mycotoxins, antibiotics, hormones, genetically modified organisms, risk material, food allergens and microorganisms. R-Biopharm’s services include project management; development and validation of biomarker-based in-vitro diagnostic devices; validation and registration, manufacturing and commercialization. The company serves biotechnology and pharmaceutical industries. It has its presence in the UK, USA, Italy, France, Brazil, Spain, Australia and China. R-Biopharm is headquartered in Darmstadt, Germany.

R-Biopharm AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
R-Biopharm AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
R-Biopharm AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
R-Biopharm AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
R-Biopharm AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
R-Biopharm AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
R-Biopharm AG, Medical Equipment, Deal Details 10
Partnerships 10
ELITechGroup and R-Biopharm Enter into Agreement 10
R-Biopharm Enters into Agreement with Bosch Healthcare 11
Gold Standard Diagnostics Enters into Distribution Agreement with R-Biopharm 12
R-Biopharm Enters into Agreement with HMNC Brain Health 13
R-Biopharm Enters into Agreement with Merck 14
Apogenix Enters into Agreement with R-Biopharm 15
R-Biopharm AG – Key Competitors 16
R-Biopharm AG – Key Employees 17
R-Biopharm AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
R-Biopharm AG, Medical Equipment, Key Facts 2
R-Biopharm AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
R-Biopharm AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
R-Biopharm AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
R-Biopharm AG, Deals By Market, 2012 to YTD 2018 8
R-Biopharm AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ELITechGroup and R-Biopharm Enter into Agreement 10
R-Biopharm Enters into Agreement with Bosch Healthcare 11
Gold Standard Diagnostics Enters into Distribution Agreement with R-Biopharm 12
R-Biopharm Enters into Agreement with HMNC Brain Health 13
R-Biopharm Enters into Agreement with Merck 14
Apogenix Enters into Agreement with R-Biopharm 15
R-Biopharm AG, Key Competitors 16
R-Biopharm AG, Key Employees 17
R-Biopharm AG, Subsidiaries 18

List of Figures
R-Biopharm AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
R-Biopharm AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
R-Biopharm AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
R-Biopharm AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
R-Biopharm AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[R-Biopharm AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務情報
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • RainDance Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR s …
  • PharmAust Ltd (PAA):企業の財務・戦略的SWOT分析
    Summary PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food …
  • JSC Gazprom Neft:企業の戦略・SWOT・財務情報
    JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report Summary JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ambac Financial Group Inc (AMBC):企業の財務・戦略的SWOT分析
    Ambac Financial Group Inc (AMBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Limacorporate SpA-医療機器分野:企業M&A・提携分析
    Summary Limacorporate SpA (Lima) is a medical device company that offers reconstructive and fixation orthopaedic solutions. The company offers large joint primary, large joint revision, extremities and fixation and promade products. It offers medical products for knee, hip, shoulder, cups, small joi …
  • Intersect ENT Inc (XENT)-医療機器分野:企業M&A・提携分析
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that provides chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Interse …
  • KBL European Private Bankers S.A.:企業の戦略・SWOT・財務情報
    KBL European Private Bankers S.A. - Strategy, SWOT and Corporate Finance Report Summary KBL European Private Bankers S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • China Resources Beer (Holdings) Co Ltd:戦略・SWOT・企業財務分析
    China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Sumitomo Electric Industries, Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Electric Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Butterfield Private Banking:企業の戦略・SWOT・財務情報
    Butterfield Private Banking - Strategy, SWOT and Corporate Finance Report Summary Butterfield Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • mBio Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary MBio Diagnostics Inc (MBio) is a medical device company that offers clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from a …
  • Logitech International SA (LOGN):企業の財務・戦略的SWOT分析
    Logitech International SA (LOGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Medicalis Corporation-医療機器分野:企業M&A・提携分析
    Summary Medicalis Corporation (Medicalis) develops radiology workflow solutions for integrated delivery networks (IDN) to automate and manage processes and improve productivity. The company’s platform solutions include decision support, referral management, and enterprise worklist. Its proprietary c …
  • Shanghai Kehua Bio-engineering Co Ltd (002022):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, ch …
  • Herman Miller Inc (MLHR):企業の財務・戦略的SWOT分析
    Herman Miller Inc (MLHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gibson Energy Inc (GEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Gibson Energy Inc (Gibson) is an independent midstream energy company. It provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids, water, oilfield waste, and refined products. Gib …
  • Cabot Oil & Gas Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Cabot Oil & Gas Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Cabot Oil & Gas Corp (Cabot) is an independent oil and gas company, which develops, and explores for oil and gas properties primarily in the continental US. It focuses on developing natural gas …
  • Dialog Group Berhad (DIALOG)-石油・ガス分野:企業M&A・提携分析
    Summary Dialog Group Berhad (Dialog) is an oil and gas services company. It provides integrated technical services. The company provides technical services for logistics and upstream assets; engineering, procurement, construction, and commissioning; plant maintenance and catalyst handling; fabricati …
  • Sapura Energy Bhd (SENERGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Sapura Energy Bhd (Sapura) formerly known as SapuraKencana Petroleum Berhad is a global provider of integrated oil and gas services and solutions. It focuses on upstream business covering exploration, development, production, as well as decommissioning and abandonment stages. The company’s s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆